Molecular Partners AG to Host Oncology Day (Virtual) Transcript
Good morning, and welcome to the Molecular Partners 2021 Oncology Day, Custom-Built Biology for patients. My name is Seth Lewis, Head of Investor Relations. And we're very pleased to have you here with us today as we highlight the recent achievements of our DARPin-based oncology portfolio.
Joining me today are members of our senior management team, including Patrick Amstutz, Chief Executive Officer; Michael Stumpp, Chief Operating Officer; Dani Steiner, Head of Research; Nicolas Leupin, Chief Medical Officer; and Anne Goubier, Head of Biology. We'll also be joined today by our guest speakers and key opinion leaders in the field of AML, Professors, Adrian Ochsenbein and Carsten Riether.
As a reminder, this is being recorded and is available for replay, but the date of this presentation is December 15, 2021. And we will be making several forward-looking statements throughout the presentation, and I would refer you to the latest presentations and disclaimers on our website should anything have changed. With
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
